Title of article
Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes
Author/Authors
Pegoraro، نويسنده , , Carla and Cecchin، نويسنده , , Denis and Gracia، نويسنده , , Lorena Simon and Warren، نويسنده , , Nicholas and Madsen، نويسنده , , Jeppe and Armes، نويسنده , , Steven P. and Lewis، نويسنده , , Andrew and MacNeil، نويسنده , , Sheila and Battaglia، نويسنده , , Giuseppe، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
10
From page
328
To page
337
Abstract
We present the efficient and stable encapsulation of doxorubicin within pH sensitive polymeric vesicles (polymersomes) for intracellular and nuclear delivery to melanoma cells. We demonstrate that PMPC25-PDPA70 polymersomes can encapsulate doxorubicin for long periods of time without significant drug release. We demonstrate that empty polymersomes are non-toxic and that they are quickly and more efficiently internalised by melanoma cells compared to healthy cells. Encapsulated doxorubicin has a strong cytotoxic effect on both healthy and cancerous cells, but when encapsulated it had a preferential effect on melanoma cells indicating that this formulation can be used to achieve an enhanced drug delivery to cancerous cells rather than to the healthy surrounding cells.
Keywords
doxorubicin , melanoma , targeted delivery , Polymersomes
Journal title
Cancer Letters
Serial Year
2013
Journal title
Cancer Letters
Record number
1822909
Link To Document